Treating cervical cancer often involves placing special devices inside the body to deliver high-dose radiation directly to the tumor. The goal is to hit the cancer hard while keeping the dose to nearby organs like the bladder, rectum, and sigmoid colon as low as possible. This balance is called the therapeutic dose window. A large review looked at how different tools and techniques affect this balance in real clinical practice.
The analysis combined data from 34 studies that screened over 1,500 articles. Doctors found that adding interstitial needles to standard tandem and ring or tandem and ovoid applicators increased the dose to the tumor by about 4 Gy. This change did not increase the radiation dose to the bladder, rectum, or sigmoid. Switching to tandem and ring applicators also improved the target dose by 3.2 Gy and reduced organ doses by 2.8 to 3.4 Gy compared to tandem and ovoid tools.
When needles were added to tandem and ring applicators, 100 percent of patient groups met the safety and effectiveness goals. For tandem and ring tools alone, 89 percent of groups met the goals. In contrast, only 43 percent of groups using tandem and ovoid tools met the goals. Adding needles to tandem and ovoid tools helped half of the groups reach the targets. The review noted that studies using needles with tandem and ring applicators showed a favorable balance between hitting the tumor and sparing healthy tissue.